Pear expects $22M in revenue this year, as it banks on growing adoption of digital therapeutics
Pear still has substantial challenges going forward, as it faces several unknowns about the long-term adoption and reimbursement of its products. The company has been operating at a net loss, seeing a $65 million loss last year.